EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship with patients and new technology.

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in the first quarter (Q1) ...

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues ... IQVIA’s vice president of industry relations—explores the current landscape of the US pharmaceutical industry by ...

Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products ...

Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) in Q1 CY2025, with sales flat year on year at $170.5 million.

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

Bio Korea 2025, South Korea's largest health and pharmaceutical industry trade fair, kicked off Wednesday, bringing together some 750 companies from across the world to showcase the latest ...

Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles.

Report Ocean has published a new report on the Saudi Arabia Pharmaceutical Continuous Manufacturing Market, delivering an extensive analysis of key factors such as market restraints, drivers, and ...